Collegium Pharmaceutical
COLL
Cars.com
CARS
New Fortress Energy
NFE
4
Precision Drilling
PDS
5
Lantheus
LNTH
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 23.45%1.11B | -7.87%4.21B | 26.65%1.17B | 2.73%1.08B | -12.71%1.39B | -45.87%900.9M | -21.14%4.57B | 182.32%923.1M | -55.77%1.05B | -30.93%1.59B |
Operating revenue | 23.45%1.11B | -7.87%4.21B | 26.65%1.17B | 2.73%1.08B | -12.71%1.39B | -45.87%900.9M | -21.14%4.57B | 182.32%923.1M | -55.77%1.05B | -30.93%1.59B |
Cost of revenue | 6.24%643.6M | -9.38%2.63B | 23.77%719M | -3.88%647.1M | -17.71%839.3M | -41.42%605.8M | -23.72%2.9B | 155.26%580.9M | -59.08%673.2M | -36.93%1.02B |
Gross profit | 58.79%468.6M | -5.25%1.58B | 31.53%450.1M | 14.44%435.1M | -3.74%547.6M | -53.17%295.1M | -16.19%1.66B | 587.46%342.2M | -48.36%380.2M | -16.73%568.9M |
Operating expense | 1.00%332.1M | -10.84%1.31B | -2.80%326.1M | -0.73%338.2M | -16.54%362.3M | -28.24%328.8M | -16.61%1.47B | 14,486.96%335.5M | -41.08%340.7M | -25.36%434.1M |
Selling and administrative expenses | 10.91%194.2M | -3.54%755.5M | 4.91%190M | 9.12%203.4M | -8.57%210.3M | -24.53%175.1M | -13.73%783.2M | 187.92%181.1M | -33.83%186.4M | -17.03%230M |
Research and development costs | -0.83%83.9M | -17.46%316.2M | -4.93%81M | -8.67%78M | -28.60%91.6M | -32.64%84.6M | -15.17%383.1M | 283.62%85.2M | -47.25%85.4M | -22.43%128.3M |
Depreciation amortization depletion | -21.85%54M | -21.43%236.5M | -20.38%55.1M | -17.56%56.8M | -20.32%60.4M | -31.31%69.1M | -24.77%301M | 587.32%69.2M | -48.81%68.9M | -45.47%75.8M |
-Depreciation and amortization | -21.85%54M | -21.43%236.5M | -20.38%55.1M | -17.56%56.8M | -20.32%60.4M | -31.31%69.1M | -24.77%301M | 587.32%69.2M | -48.81%68.9M | -45.47%75.8M |
Operating profit | 505.04%136.5M | 36.47%268.7M | 1,750.75%124M | 145.32%96.9M | 37.46%185.3M | -119.59%-33.7M | -12.91%196.9M | 109.24%6.7M | -75.02%39.5M | 32.68%134.8M |
Net non-operating interest income expense | -3.17%-169.3M | -1.70%-676M | -8.05%-181.1M | 1.49%-165.4M | 0.72%-165.4M | -0.92%-164.1M | -13.41%-664.7M | -4.49%-167.6M | -11.71%-167.9M | -19.34%-166.6M |
Non-operating interest income | 22.22%4.4M | -1.80%10.9M | -21.21%2.6M | -23.53%2.6M | 10.53%2.1M | 44.00%3.6M | 296.43%11.1M | 230.00%3.3M | 466.67%3.4M | 280.00%1.9M |
Non-operating interest expense | 3.58%173.7M | 1.64%686.9M | 7.49%183.7M | -1.93%168M | -0.59%167.5M | 1.57%167.7M | 14.76%675.8M | 5.89%170.9M | 13.52%171.3M | 20.27%168.5M |
Other net income (expense) | 35.20%-11.6M | 99.62%-2M | 105.54%4.5M | 99.66%-1.5M | 132.09%11.2M | -209.15%-17.9M | 54.31%-530.6M | 92.72%-81.2M | -15,268.97%-439.9M | 6.93%-34.9M |
Gain on sale of security | -332.35%-7.9M | ---- | ---- | -1,940.00%-10.2M | 118.75%300K | 300.00%3.4M | ---- | ---- | -113.89%-500K | -194.12%-1.6M |
Special income (charges) | 88.10%-2.5M | 97.95%-12.2M | 96.86%-4M | 101.18%5.3M | 120.49%7.5M | -289.19%-21M | 48.64%-596.5M | 88.50%-127.5M | -17,816.00%-447.9M | 4.94%-36.6M |
-Less:Restructuring and merger&acquisition | -63.40%11.2M | 46.22%36.7M | 133.89%6.1M | -104.09%-900K | -97.54%900K | 375.68%30.6M | -39.95%25.1M | -59.29%-18M | 780.00%22M | -4.94%36.6M |
-Write off | ---- | --0 | --0 | --0 | ---- | ---- | -48.96%571.4M | -87.00%145.5M | --425.9M | ---- |
-Gain on sale of business | -9.38%8.7M | --24.5M | --2.1M | --4.4M | --8.4M | --9.6M | --0 | --0 | --0 | --0 |
Other non- operating income (expenses) | -300.00%-1.2M | -84.52%10.2M | -92.16%3.7M | -60.00%3.4M | 3.03%3.4M | -104.29%-300K | --65.9M | --47.2M | 372.22%8.5M | 571.43%3.3M |
Income before tax | 79.42%-44.4M | 59.00%-409.3M | 78.27%-52.6M | 87.68%-70M | 146.63%31.1M | -936.05%-215.7M | 34.38%-998.4M | 82.03%-242.1M | -5,411.21%-568.3M | 11.66%-66.7M |
Income tax | -1,328.31%-334.1M | -46.92%51.7M | -93.89%10.5M | 177.39%26.7M | -1,113.89%-43.7M | 780.00%27.2M | 206.68%97.4M | 279.90%171.8M | -182.79%-34.5M | 75.17%-3.6M |
Net income | 334.94%784M | 79.06%-315.5M | 105.56%32.3M | 96.02%-33M | 144.22%44.4M | -9,914.71%-333.7M | -17.09%-1.51B | 47.60%-581.1M | -3,718.78%-828.7M | -64.59%-100.4M |
Net income continuous Operations | 219.27%289.7M | 57.93%-461M | 84.75%-63.1M | 81.88%-96.7M | 218.54%74.8M | -915.10%-242.9M | 23.38%-1.1B | 66.94%-413.9M | -2,431.00%-533.8M | -3.44%-63.1M |
Net income discontinuous operations | 644.38%494.3M | 135.40%145.5M | 157.06%95.4M | 121.60%63.7M | 18.50%-30.4M | -243.94%-90.8M | -387.01%-411M | ---167.2M | ---294.9M | ---37.3M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 334.94%784M | 79.06%-315.5M | 105.56%32.3M | 96.02%-33M | 144.22%44.4M | -9,914.71%-333.7M | -17.09%-1.51B | 47.60%-581.1M | -3,718.78%-828.7M | -64.59%-100.4M |
Preferred stock dividends | 5.63%16.9M | 5.50%65.2M | 4.40%16.6M | 5.81%16.4M | 5.88%16.2M | 5.96%16M | 4.75%61.8M | 6.71%15.9M | 4.03%15.5M | 4.08%15.3M |
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 319.36%767.1M | 75.73%-380.7M | 102.63%15.7M | 94.15%-49.4M | 124.37%28.2M | -2,888.89%-349.7M | -16.55%-1.57B | 46.88%-597M | -10,652.50%-844.2M | -52.84%-115.7M |
Basic earnings per share | 315.15%3.55 | 76.08%-1.78 | 98.23%-0.05 | 94.22%-0.23 | 123.64%0.13 | -2,650.00%-1.65 | -14.64%-7.44 | 47.68%-2.82 | -10,050.00%-3.98 | -52.78%-0.55 |
Diluted earnings per share | 274.55%2.88 | 76.08%-1.78 | 98.23%-0.05 | 94.22%-0.23 | 123.64%0.13 | -2,650.00%-1.65 | -14.64%-7.44 | 47.68%-2.82 | -10,050.00%-3.98 | -52.78%-0.55 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |